Clinical Trials Logo
  1. Home
  2. AKI
  3. NCT04342975

Protection From Acute Kidney Injury (AKI) With Basis™ Treatment

AKI Clinical Trial

Official title:
A Phase II, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Efficacy of BASIS™ (Nicotinamide Riboside and Pterostilbene) Treatment for Kidney Protection in Patients Treated by Complex Aortic Aneurysm Repair and Aortic Arch Reconstruction

Clinical Trial Summary

This study is a single-center, prospective, randomized, double-blinded, placebo-controlled phase II clinical trial to evaluate the efficacy of "NAD+ supplementation" with Basis™ (Nicotinamide Riboside and Pterostilbene) in preventing acute kidney injury (AKI) in patients undergoing complex aortic aneurysm repair and open aortic arch reconstruction.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04342975
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 2
Start date December 1, 2020
Completion date March 14, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT04112953 - Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Terminated NCT04530448 - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization Phase 4
Active, not recruiting NCT04008810 - Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
Recruiting NCT04597034 - Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 N/A
Completed NCT04458571 - Effect of CRRT Duration on Solute Removal
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT05094154 - Effect of Antibiotic Choice On ReNal Outcomes (ACORN) Phase 4
Enrolling by invitation NCT04491227 - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Not yet recruiting NCT05382078 - Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
Recruiting NCT04351906 - Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome N/A
Recruiting NCT06416761 - Genetics in the Progression of Nephropathies
Completed NCT04762524 - The Impact of CRRT Modality on Filter Life N/A
Completed NCT04048525 - Cytokine Removal With CVVHD Compared to CVVH N/A
Completed NCT04788394 - Renal Involvement in Hospitalized Children With COVID-19
Recruiting NCT04474249 - Follow-up of Critical COVID-19 Patients
Completed NCT04517630 - Renal Biomarkers in AKI and COVID-19
Completed NCT04407156 - Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom
Recruiting NCT04895384 - El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)
Completed NCT03070353 - Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury Phase 2/Phase 3